ArticlePharmacoEconomics - open2018

Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006-2014.

David Nathanson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.